Use of an adenosine A3 receptor agonist for inhibition of viral replication
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 15, 2009
Grant Date -
Jun 3, 2004
app pub date -
Jan 13, 2002
filing date -
Jan 16, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention concerns the use of an active ingredient selected from the group consisting of agonists of the adenosine receptor system, for inhibiting viral replication in cells. In particular, the invention provides a composition and method for inhibiting viral replication in cells, the method comprising presenting to the cells an effective amount of the active ingredient. According to one embodiment, the adenosine agonist is an A3 receptor agonist (A3RAg). The invention is particularly useful, for although not limited to, inhibiting the replication of HIV virus in human cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully